Overview
- Judicial records now list 122 deceased patients from 13 hospitals and clinics across Buenos Aires, Santa Fe and Córdoba provinces and the city of Buenos Aires.
- Forensic teams and the Malbrán institute reported Ralstonia mannitolilytica and Klebsiella pneumoniae in both seized ampoules and patient samples, with genomic matching still in progress.
- The Cuerpo Médico Forense found that infections linked to the fentanyl aggravated conditions enough to cause death in 12 of the first 20 cases reviewed.
- Detentions include HLB Pharma owner Ariel García Furfaro and technical directors tied to lots 31.202 and 31.244 produced in December 2024 and released starting in January.
- An 11-year-old’s family filed a federal complaint alleging permanent harm from contaminated fentanyl, and Santa Fe authorities are separately investigating the disappearance of 68 fentanyl ampoules at Hospital Iturraspe not tied to the implicated brand.